A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Condition:   Primary Immune Thrombocytopenia (ITP) Interventions:   Biological: efgartigimod;   Other: Placebo Sponsor:   argenx BVBA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials